These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19415980)

  • 21. Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking.
    Kim J; Jeong IH; Kim CS; Lee YM; Kim JM; Kim JS
    Arch Pharm Res; 2011 Mar; 34(3):495-500. PubMed ID: 21547683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spiro cross-links: representatives of a new class of glycoxidation products.
    Reihl O; Biemel KM; Eipper W; Lederer MO; Schwack W
    J Agric Food Chem; 2003 Jul; 51(16):4810-8. PubMed ID: 14705917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose.
    Ferreira AE; Ponces Freire AM; Voit EO
    Biochem J; 2003 Nov; 376(Pt 1):109-21. PubMed ID: 12911334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the amadori product in the complications of diabetes.
    Monnier VM; Sell DR; Dai Z; Nemet I; Collard F; Zhang J
    Ann N Y Acad Sci; 2008 Apr; 1126():81-8. PubMed ID: 18448799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonenzymatic glycosylation of tissue and blood proteins.
    Emekli N
    J Marmara Univ Dent Fac; 1996 Sep; 2(2-3):530-4. PubMed ID: 9569811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The maillard reaction in eye diseases.
    Stitt AW
    Ann N Y Acad Sci; 2005 Jun; 1043():582-97. PubMed ID: 16037281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiscale mechanical effects of native collagen cross-linking in tendon.
    Eekhoff JD; Fang F; Lake SP
    Connect Tissue Res; 2018 Sep; 59(5):410-422. PubMed ID: 29873266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications.
    Sensi M; Pricci F; Andreani D; Di Mario U
    Diabetes Res; 1991 Jan; 16(1):1-9. PubMed ID: 1818791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fe2+-catalyzed non-enzymatic glycosylation alters collagen conformation during AGE-collagen formation in vitro.
    Xiao H; Cai G; Liu M
    Arch Biochem Biophys; 2007 Dec; 468(2):183-92. PubMed ID: 17964528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis.
    Verzijl N; DeGroot J; Ben ZC; Brau-Benjamin O; Maroudas A; Bank RA; Mizrahi J; Schalkwijk CG; Thorpe SR; Baynes JW; Bijlsma JW; Lafeber FP; TeKoppele JM
    Arthritis Rheum; 2002 Jan; 46(1):114-23. PubMed ID: 11822407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Native protein glycoxidation and aging.
    Meli M; Frey J; Perier C
    J Nutr Health Aging; 2003; 7(4):263-6. PubMed ID: 12917752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel inhibitors of advanced glycation endproducts (part II).
    Rahbar S; Yerneni KK; Scott S; Gonzales N; Lalezari I
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):360-6. PubMed ID: 11032758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of enzymatic cross-links and non-enzymatic cross-link, advanced glycation end products, as a determinant of bone quality in osteoporosis and diabetes].
    Saito M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():209-13. PubMed ID: 18161108
    [No Abstract]   [Full Text] [Related]  

  • 34. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced glycation end product (age) inhibitors and their therapeutic implications in diseases.
    Takeuchi M; Yamagishi S; Iwaki M; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(2-3):95-101. PubMed ID: 15689055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Advanced Glycation Endproducts in Rat Tail Collagen and Correlation to Tendon Stiffening.
    Jost T; Zipprich A; Glomb MA
    J Agric Food Chem; 2018 Apr; 66(15):3957-3965. PubMed ID: 29620898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders.
    Yamagishi S
    Rejuvenation Res; 2012 Dec; 15(6):564-72. PubMed ID: 22950433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of Withania somnifera (Solanaceae) on collagen glycation and cross-linking.
    Babu PV; Gokulakrishnan A; Dhandayuthabani R; Ameethkhan D; Kumar CV; Ahamed MI
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Jun; 147(2):308-13. PubMed ID: 17329138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.